747058
Last Update Posted: 2010-01-08
Recruiting has ended
Males accepted | 21 Years-55 Years |
28 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects
The purpose of this study is to determine the safety and tolerability of PF-03864086 in healthy male human volunteers. Determine the pharmacokinetics (calculations of the rate of elimination of PF-03864086 from the body once the compound is ingested).
Eligibility
Relevant conditions:
Pain
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov